UQCRB and neoplasm: In conclusion, our results are in agreement with recent data suggesting that the UQCRB subunit of Complex III in the mitochondrial respiratory chain plays a pivotal role in hypoxic signaling, and identifies UQCRB as a potential novel therapeutic target for the development of drugs able to counteract tumor progression due to the EMT, by blocking mitochondrial ROS production [21,23,54].